Scientific Industries chair receives stock option awards

Scientific Industries Inc. director and chairman John A. Moore received stock option awards as compensation.

Rhea-AI Filing Summary

Scientific Industries Inc. director and chairman John A. Moore received stock option awards as compensation. He was granted stock options covering 230,000 shares of common stock and an additional 30,000-share option, each with a conversion price of $0.6000 per share.

The filing shows these awards were granted in lieu of cash compensation and vest over one year at a rate of 1/12 per month. Following these grants, Moore holds stock options covering 916,871 shares, giving him additional long-term equity exposure but reflecting routine, compensation-related awards rather than open-market purchases.

Insider Trade Summary

Grant/Award: 260,000 shares

Grant/Award 2 txns

Insider MOORE JOHN A

Role Chairman of the Board

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	230,000	$0.00	$0.00
Grant/Award	Stock Option	30,000	$0.00	$0.00

Holdings After Transaction: Stock Option — 916,871 contracts (Direct)

Footnotes (1)

1. F1. Options granted to Registrant in lieu of cash compensation. Vesting is 1 year - 1/12th per month.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SCND chairman John A. Moore report on this Form 4?

John A. Moore reported receiving stock option awards. He was granted options for 230,000 and 30,000 shares of Scientific Industries common stock at a $0.6000 exercise price, expanding his equity-based compensation and aligning pay with the company’s share performance over time.

How many stock options did John A. Moore receive from Scientific Industries (SCND)?

Moore received options on a total of 260,000 shares. The Form 4 shows one grant for 230,000 shares and another for 30,000 shares of common stock, both structured as stock options granted as compensation instead of cash payments.

What is the exercise price and term of John A. Moore’s SCND stock options?

The options have a $0.6000 per share exercise price and long duration. Both grants are exercisable at this price and carry an expiration date of February 17, 2036, providing a long window in which the options may be exercised.

How do John A. Moore’s new SCND options vest?

The options vest over one year in monthly installments. According to the footnote, they were granted in lieu of cash compensation and vest on a one-year schedule, with 1/12 of the options vesting each month during that period.

What are John A. Moore’s SCND option holdings after these grants?

After the reported grants, Moore holds options on 916,871 shares. The Form 4 shows this total option position following the two new awards, reflecting his overall derivative-based exposure to Scientific Industries common stock.

Were John A. Moore’s SCND option grants open-market purchases?

No, they were compensation-related grants, not market buys. The filing labels the transactions as awards under code A, granted in lieu of cash compensation, meaning no open-market purchases of Scientific Industries shares occurred in these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 03:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOORE JOHN A

(Last) (First) (Middle)

403 MARSH LANE

(Street)

WILMINGTON DE 19807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ SCND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman of the Board

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.6	02/17/2026	02/17/2026	A		230,000		02/17/2027(1)	02/17/2036	Common Stock	230,000	$0	886,871	D
Stock Option	$0.6	02/17/2026	02/17/2026	A		30,000		02/17/2027	02/17/2036	Common Stock	30,000	$0	916,871	D

Explanation of Responses:

1. Options granted to Registrant in lieu of cash compensation. Vesting is 1 year - 1/12th per month.

	John Moore	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.